Skip to content

Clinical trials

Expanded access Leukemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Expanded access Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available6
Approved for marketing2
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AstraZeneca1
BTG International Inc.1
Barbara Ann Karmanos Cancer Institute1
Children's Hospital of Philadelphia1
Christopher Dvorak1
OHSU Knight Cancer Institute1
Syndax Pharmaceuticals1
UNC Lineberger Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia10
Lymphoma4
Leukemia, Myeloid, Acute3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Bone Marrow Failure Disorders2
Immune System Diseases2
Immunologic Deficiency Syndromes2
Immunoproliferative Disorders2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Myelodysplastic Syndromes2

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.